The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue on its mission to create new drugs and medicines using AI.

Isomorphic Labs raised $600 million in its first external funding round, led by Thrive Capital with participation from GV and ...

AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict the shape of not only proteins but also DNA, RNA and other biological ...

Alphabet’s Isomorphic stacks two new deals with Lilly, Novartis worth nearly $3B ahead of JPM Isomorphic builds AI models to design potential drugs, most recently AlphaFold 3, a Google DeepMind ...

Jefferies analyst Brent Thill maintained a Buy rating on Alphabet Class A (GOOGL – Research Report) today and set a price target of $200.00.